Food and Drug Administration (FDA)
5600 Fishers Lane
Rockville
Maryland
20857
United States
Tel: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332)
Website: http://www.fda.gov/
About Food and Drug Administration (FDA)
FDA Overview:
The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.
•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.
FDA's Mission Statement
The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.
26415 articles about Food and Drug Administration (FDA)
-
ISPE to Feature FDA Inspection Enforcement Trends Seminar at 2011 Tampa Conference
1/5/2011
-
FDA Grants Supplemental Approval for ACTEMRA(R) (tocilizumab)
1/5/2011
-
eC-SSRS Solution from eResearch Technology Inc. (ERT) Facilitates Compliance with New FDA Guidance on Suicidality Assessment in Clinical Trials
1/5/2011
-
Crospon Receives FDA Approval for Latest EndoFLIP Product
1/5/2011
-
Aldagen, Inc. Announces FDA Clearance of IND to Begin Phase 2 Study in Ischemic Stroke With Regenerative Cell Therapy
1/5/2011
-
W. L. Gore & Associates, Inc. Receives FDA Approval for Innovative GORE(R) C3 Delivery System for GORE(R) EXCLUDER(R) AAA Endoprosthesis
1/4/2011
-
Revolutions Medical Corporation Completes Revision of Exclusive Rights to License Additional Patents on FDA Approved Breast Biopsy Localization System
1/4/2011
-
ImmunoCellular Therapeutics, Ltd Receives FDA Approval to Commence Phase II Trial of ICT-107
1/4/2011
-
Hemispherx Biopharma Release: FDA Authorizes Alferon LDO Clinical Study for Treatment and Prevention of Influenza
1/4/2011
-
FDA and Allon Therapeutics, Inc. Agree on Special Protocol Assessment for Pivotal Trial in Progressive Supranuclear Palsy
1/4/2011
-
Smith & Nephew plc Responds to FDA's Warning Letter, Sees No Impact
1/3/2011
-
Senesco Technologies, Inc. Lead Therapeutic Candidate SNS01-T Granted Orphan Drug Status from FDA for Treatment of Multiple Myeloma
1/3/2011
-
FDA Approves New Dosage Strength for Tibotec Therapeutics's INTELENCE(R)
1/3/2011
-
Drug Approvals Slipped in 2010; Some Potential Blockbusters Suffered Delays Amid FDA's Tougher Safety Stance
1/3/2011
-
Advanced Cell Technology Receives FDA Clearance For Clinical Trials Using Embryonic Stem Cells to Treat Age-Related Macular Degeneration
1/3/2011
-
FDA Panel Wants Tougher Restrictions on Opioids
12/30/2010
-
FDA Barred from Regulating E-cigarettes as Medical Devices
12/30/2010
-
Regeneron Pharmaceuticals, Inc. Says U.S. FDA Halts Development of Pain Killer After Bone Death
12/29/2010
-
Operator-Dependent Results Cloud Picture in FDA 2002 Approval of Medtronic, Inc.'s BMP-2
12/29/2010
-
Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE(R) Pediatric Ulcerative Colitis Indication
12/29/2010